Literature DB >> 8658362

Air pollution: brown skies research.

A E Tattersfield1.   

Abstract

Direct information on the health effects of air pollution in humans relies mainly on chamber studies and epidemiological studies. Although chamber studies have limitations they allow the acute effects of individual pollutants to be studied in well characterised subjects under controlled conditions. Most chamber studies have shown relatively small falls in lung function and relatively small increases in bronchial reactivity at the concentrations of ozone, SO2, and NO2 that occur even during high pollution episodes in the UK. The possible exception is SO2 where sensitive asthmatic patients may show a greater response at concentrations that are seen from time to time in certain areas and in proximity to power stations. There is no convincing evidence of potentiation between pollutants in chamber studies. Epidemiological studies are more difficult to carry out and require considerable epidemiological and statistical expertise to deal with the main problem-confounding by other factors. Although the health effects seen with current levels of pollution are small compared with those seen in the 1950s and close to the limits of detection, this should not be interpreted as being unimportant. A small effect may have large consequences when the population exposed is large (the whole population in this case). Recent data suggest that particles have more important health effects than the pollutant gases that have been studied. Much of this information comes from the USA though the findings are probably applicable in the UK. More information is needed on the size of the health effects that occur during the three types of air pollution episodes seen in this country and the relative contributions of particles, pollutant gases, pollen, and other factors such as temperature. Research into air pollution declined in the UK following the introduction of the Clean Air Acts; it is now increasing again following pressure from certain individuals and ginger groups, including the British Lung Foundation, and its potential importance is recognised by the Department of Health. This article has concentrated on the acute effects of air pollution episodes, though the long term effects of acute episodes of air pollution and chronic high levels of pollutants is equally, if not more, important. Roger Altounyan had severe chest-disease attributed to asthma and personal pollution (cigarette smoke). But did the smog episodes in Manchester in the 1950s or subsequent vehicle related pollution play a part and did they interact with the bronchial challenges he underwent over the years (estimated at 3000)? Air pollution is a product of the way that society chooses to live. Obtaining an accurate picture of the extent to which current levels of air pollution cause acute and chronic effects on health is important if sensible choices are to be made by individuals and society about the processes contributing to air pollution. It is also important for patients with or at risk of developing cardiorespiratory disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8658362      PMCID: PMC472793          DOI: 10.1136/thx.51.1.13

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  33 in total

1.  Ozone-induced inflammation in the lower airways of human subjects.

Authors:  H S Koren; R B Devlin; D E Graham; R Mann; M P McGee; D H Horstman; W J Kozumbo; S Becker; D E House; W F McDonnell
Journal:  Am Rev Respir Dis       Date:  1989-02

2.  Exposure to antomobile exhaust. I. Prevalence of respiratory symptoms and disease.

Authors:  F E Speizer; B G Ferris
Journal:  Arch Environ Health       Date:  1973-06

3.  Comparative respiratory effects of ozone and ambient oxidant pollution exposure during heavy exercise.

Authors:  E L Avol; W S Linn; T G Venet; D A Shamoo; J D Hackney
Journal:  J Air Pollut Control Assoc       Date:  1984-08

4.  Adaptation to ozone: duration of effect.

Authors:  S M Horvath; J A Gliner; L J Folinsbee
Journal:  Am Rev Respir Dis       Date:  1981-05

5.  Airway sensitivity of asthmatics to sulfur dioxide.

Authors:  D Horstman; L J Roger; H Kehrl; M Hazucha
Journal:  Toxicol Ind Health       Date:  1986-09       Impact factor: 2.273

6.  Replicated dose-response study of sulfur dioxide effects in normal, atopic, and asthmatic volunteers.

Authors:  W S Linn; E L Avol; R C Peng; D A Shamoo; J D Hackney
Journal:  Am Rev Respir Dis       Date:  1987-11

7.  Dose-response study of asthmatic volunteers exposed to nitrogen dioxide during intermittent exercise.

Authors:  W S Linn; D A Shamoo; E L Avol; J D Whynot; K R Anderson; T G Venet; J D Hackney
Journal:  Arch Environ Health       Date:  1986 Sep-Oct

Review 8.  Relationship between ozone exposure and pulmonary function changes.

Authors:  M J Hazucha
Journal:  J Appl Physiol (1985)       Date:  1987-04

9.  Health effects of an air pollution episode in London, December 1991.

Authors:  H R Anderson; E S Limb; J M Bland; A Ponce de Leon; D P Strachan; J S Bower
Journal:  Thorax       Date:  1995-11       Impact factor: 9.139

10.  [Bronchial response to allergens after controlled NO2 exposure (author's transl)].

Authors:  J Orehek; F Grimaldi; E Muls; J P Durand; A Viala; J Charpin
Journal:  Bull Eur Physiopathol Respir       Date:  1981 Nov-Dec
View more
  3 in total

1.  Respiratory effects of air pollution in chronic obstructive pulmonary disease: a three month prospective study.

Authors:  E S Harré; P D Price; R B Ayrey; L J Toop; I R Martin; G I Town
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

2.  Effect of short-term exposure to gaseous pollution on asthma hospitalisation in children: a bi-directional case-crossover analysis.

Authors:  M Lin; Y Chen; R T Burnett; P J Villeneuve; D Krewski
Journal:  J Epidemiol Community Health       Date:  2003-01       Impact factor: 3.710

Review 3.  Smog induces oxidative stress and microbiota disruption.

Authors:  Tit-Yee Wong
Journal:  J Food Drug Anal       Date:  2017-03-15       Impact factor: 6.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.